Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
US Stock Insider Trading | Baimalin Pharmaceuticals disclosed one insider transaction on March 12
On March 12, 2026, BioMarin Pharmaceutical (BMRN) disclosed 1 insider trading transaction involving company insiders. Executive Guyer Charles Greg sold 16.5k shares on March 11, 2026.
【Recent Insider Transactions】
【Company Profile】
Biomarin Pharmaceutical Inc. was incorporated in Delaware in October 1996 and began operations on March 21, 1997. The company is a global biotechnology company dedicated to turning the promise of gene discoveries into drugs that will have a profound impact on the lives of every patient. T. BioMarin selects candidate products for diseases and conditions with significant unmet medical needs—these diseases and conditions have a strong biological understanding and offer opportunities to be first to market or to provide products that are better than existing ones. The company’s product portfolio consists of four approved products and multiple research pipeline candidate products.